FDA Inspection 1194962 — Franklin Douglis, M.D.
The FDA completed an inspection of Franklin Douglis, M.D. on Jan 11, 2023 in Conroe, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Conroe, TX (United States)
Additional Details
Clinical Investigator (CI)